| Literature DB >> 18266036 |
Emma J Eshuis1, Sebastiaan W Polle, J Frederik Slors, Daan W Hommes, Mirjam A G Sprangers, Dirk J Gouma, Willem A Bemelman.
Abstract
PURPOSE: Several studies have compared conventional open ileocolic resection with a laparoscopic-assisted approach. However, long-term outcome after laparoscopic-assisted ileocolic resection remains to be determined. This study was designed to compare long-term results of surgical recurrence, quality of life, body image, and cosmesis in patients who underwent laparoscopic-assisted or open ileocolic resection for Crohn's disease.Entities:
Mesh:
Year: 2008 PMID: 18266036 PMCID: PMC2440934 DOI: 10.1007/s10350-008-9195-6
Source DB: PubMed Journal: Dis Colon Rectum ISSN: 0012-3706 Impact factor: 4.585
Figure 1Flowchart. SF-36 = Short Form-36 health survey; GIQLI = Gastrointestinal Quality of Life Index; BIQ = body image questionnaire.
Characteristics of 71 patients available for clinical outcome analysis
| Open group (n = 44) | Lap group (n = 27) |
| |
|---|---|---|---|
| Male/female ratio | 10/34 | 7/20 | 0.759† |
| Age (yr)* | 44 (26–85) | 40 (26–66) | 0.139‡ |
| BMI (kg/m2) | 23.14 (16.41–34.63) | 23.87 (19.11–34.54) | 0.441‡ |
| Follow-up (yr) | 0.384‡ | ||
| Mean (range) | 8.6 (4.2–10.41) | 8.3 (6.3–10.2) | |
| Median | 8.7 | 8.6 | |
| No. of patients smoking at the end of study period (%) | 18 (41) | 15 (56) | 0.311† |
| No. of patients smoking at time of ileocolic resection (%) | 21 (48) | 14 (52) | 0.736† |
| Length of resected bowel (cm) | 25.27 (5–80) | 23.76 (3–60) | 0.683‡ |
| Type of anastomosis (%) | 0.189† | ||
| S-S | 11 (25) | 10 (37) | |
| E-S/S-E | 29 (66) | 12 (45) | |
| E-E | 4 (9) | 5 (18) | |
| Postoperative immunosuppression prophylaxis (%) | 11 (25) | 4 (15) | 0.307† |
| Azathioprine | 8 (18) | 0 | |
| Budesonide | 2 (5) | 3 (11) | |
| Methotrexate | 1 (2) | 0 | |
| Prednisone, for 2 years | 0 | 1 (4) | |
| Pentasa/salofalk/mesalazine (%) | 13 (30) | 12 (44) | 0.202† |
| Additional procedures at time of ileocolic resection (%) | 7 (16) | 10 (37) | 0.043† |
| No. of patients having perianal fistulas at time of ileocolic resection (%) | 4 (9) | 3 (11) | 1† |
| Mortality | 3 | 0 | 0.283† |
Lap = laparoscopic-assisted; BMI = body mass index; S-S = side-side; E-S/S-E = end-side or side-end; E-E = end-end.
*Age at time of follow-up; age of the patients who died was determined at the date of death.
†Chi-squared test or Fisher’s exact test.
‡Mann-Whitney U test.
Intestinal disease recurrence for 71 patients with complete follow-up
| Open group (n = 44) | Lap group (n = 27) |
| |
|---|---|---|---|
| No intestinal recurrence | 18 (41) | 6 (22) | 0.106 |
| Intestinal recurrence managed at the outpatient department (never readmission) | 10 (23) | 7 (26) | 0.759 |
| Intestinal disease recurrence managed by conservative treatment (never re-resection) | 6 (14) | 8 (30) | 0.1 |
| Medication | 2 | 3 | |
| Combination | 4 | 5 | |
| Med, npo, df | 2 | 4 | |
| Nasogastric tube, npo | 0 | 1 | |
| Med, npo, nasogastric tube | 1 | 0 | |
| Med, npo, nasogastric tube, balloon dilatation | 1 | 0 | |
| Intestinal recurrence requiring re-resection | 10 (23) | 6 (22) | 0.961 |
| Neoterminal ileum and ascending colon | 7 (16) | 6 (22) | |
| Stenosis | 5 | 6 | |
| Fistulizing disease | 2 | 0 | |
| Jejunum | 1 (2) | 0 (0) | |
| Stenosis | 1 | 0 | |
| Fistulizing disease | 0 | 0 | |
| Sigmoid | 2 (5) | 0 (0) | |
| Stenosis | 1 | 0 | |
| Fistulizing disease | 1 | 0 |
Lap = laparoscopic-assisted; med = medication prescribed; npo = nihil per os; df = drip feed.
Data are numbers with percentages in parentheses unless othewise indicated.
*Chi-squared test or Fisher’s exact test.
Figure 2Analysis of re-resection-free survival (P = 0.982).
Odds ratio, 95 percent CI, and P values of patient characteristics as potential confounding factors regardless of study-arm for all four primary outcome parameters
| Odds ratio | 95% CI |
| |
|---|---|---|---|
| No intestinal disease recurrence | |||
| Gender | 0.9 | 0.3–2.9 | 0.882 |
| Age (dichotomized at median age of 37.7 yr) | 0.8 | 0.3–2.2 | 0.677 |
| BMI (dichotomized at median BMI of 23) | 1.2 | 0.5–3.3 | 0.671 |
| No. of patients smoking at time of ileocolic resection | 0.5 | 0.2–1.3 | 0.155 |
| Length of resected bowel (dichotomized at median length of 20 cm) | 0.7 | 0.3–2 | 0.541 |
| Postoperative immunosuppression prophylaxis | 0.2 | 0.049–1.2 | 0.059 |
| Additional procedures | 0.8 | 0.2–2.5 | 0.661 |
| No. of patients having fistulas at time of ileocolic resection | 0.3 | 0.3–2.6 | 0.41 |
| Intestinal recurrence managed at the outpatient department (never readmission) | |||
| Gender | 1 | 0.3–3.7 | 0.963 |
| Age (dichotomized at median age of 37.7 yr) | 0.9 | 0.3–2.6 | 0.832 |
| BMI (dichotomized at median BMI of 23) | 0.5 | 0.2–1.7 | 0.289 |
| No. of patients smoking at time of ileocolic resection | 0.9 | 0.3–2.6 | 0.832 |
| Length of resected bowel (dichotomized at median length of 20 cm) | 1.4 | 0.4–4.2 | 0.593 |
| Postoperative immunosuppression prophylaxis | 1.2 | 0.3–4.4 | 0.781 |
| Additional procedures | 1 | 0.3–3.5 | 0.963 |
| No. of patients having fistulas at time of ileocolic resection | 2.7 | 0.5–13.4 | 0.217 |
| Intestinal disease recurrence managed by conservative treatment (never re-resection) | |||
| Gender | 1.2 | 0.3–4.9 | 0.806 |
| Age (dichotomized at median age of 37.7 yr) | 3.2 | 0.9–11.4 | 0.065 |
| BMI (dichotomized at median BMI of 23) | 1.7 | 0.5–5.6 | 0.372 |
| No. of patients smoking at time of ileocolic resection | 1.5 | 0.5–4.8 | 0.512 |
| Length of resected bowel (dichotomized at median length of 20 cm) | 1.3 | 0.4–4.4 | 0.663 |
| Postoperative immunosuppression profylaxis | 1 | 0.2–4.3 | 0.975 |
| Additional procedures | 2.1 | 0.6–7.4 | 0.249 |
| No. of patients having fistulas at time of ileocolic resection | 1.7 | 0.3–10 | 0.535 |
| Intestinal recurrence requiring re-resection | |||
| Gender | 0.9 | 0.3–3.4 | 0.91 |
| Age (dichotomized at median age of 37.7 yr) | 0.5 | 0.2–1.7 | 0.284 |
| BMI (dichotomized at median BMI of 23) | 0.9 | 0.3–2.7 | 0.804 |
| No. of patients smoking at time of ileocolic resection | 2 | 0.6–6.3 | 0.23 |
| Length of resected bowel (dichotomized at median length of 20 cm) | 0.9 | 0.3–2.6 | 0.788 |
| Postoperative immunosuppression profylaxis | 3.1 | 0.9–10.6 | 0.068 |
| Additional procedures | 0.7 | 0.2–2.7 | 0.58 |
| No. of patients having fistulas at time of ileocolic resection | 0.5 | 0.1–4.9 | 0.582 |
CI = confidence interval; BMI = body mass index.
Figure 3Analysis of SF-36 scores. SF-36 = Short Form-36 health survey; Lap = laparoscopic-assisted; PCS = physical component score; MCS = mental component score.
Results of the BIQ after open compared with laparoscopic ileocolic resection for 61 patients who completed the questionnaires
| Open group (n = 38) | Lap group (n = 23) |
| |
|---|---|---|---|
| Body image scale | 15.63 (6–20) | 16.3 (7–20) | 0.512 |
| Cosmetic scale | 13.33 (3–24) | 19.61 (7–24) | 0 |
Lap = laparoscopic-assisted; BIQ = body image questionnaire.
Data are means with ranges in parentheses unless otherwise indicated.
* Student’s t-test.
Results of the PSQ after open compared with laparoscopic ileocolic resection for 61 patients who completed the questionnaires
| Open group (n = 38) | Lap group (n = 23) |
| |
|---|---|---|---|
| Rating own scars before seeing pictures | 5.5 | 8 | 0† |
| Rating pictures of other approach | 8.3 | 5.5 | 0† |
| Rating of own scars after seeing pictures | 4.8 | 8.4 | 0† |
| Difference (before – after) | −0.7 ( | +0.4 ( | |
| Preference for specific approach | 0.082‡ | ||
| Open | 4 (10.5) | 1 (4.3) | |
| Laparoscopic | 25 (65.8) | 21 (91.3) | |
| No preference | 8 (21.1) | 1 (4.3) | |
| No answer | 1 (2.6) | 0 | |
| Personal additional fee to undergo the laparoscopic approach (in Euros) | 0.039‡ | ||
| Nothing | 25 (65.8) | 10 (43.5) | |
| 0–499 | 6 (15.8) | 1 (4.3) | |
| 499–999 | 1 (2.6) | 3 (13) | |
| >1,000 | 5 (13.2) | 8 (34.8) | |
| No answer | 1 (2.6) | 1 (4.3) |
Lap = laparoscopic-assisted; PSQ = photo series questionnaire.
Data are numbers with percentages in parentheses unless othewise indicated.
*Wilcoxon’s signed-rank test.
†Mann Whitney U test.
‡Chi-squared test or Fisher’s exact test.